Geron Corp (GERN)
3.69
+0.11
(+3.07%)
USD |
NASDAQ |
Apr 17, 16:00
3.68
-0.01
(-0.27%)
After-Hours: 20:00
Geron Free Cash Flow: -168.57M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -168.57M |
| September 30, 2023 | -162.89M |
| June 30, 2023 | -141.61M |
| March 31, 2023 | -140.52M |
| December 31, 2022 | -127.81M |
| September 30, 2022 | -114.76M |
| June 30, 2022 | -107.94M |
| March 31, 2022 | -97.04M |
| December 31, 2021 | -95.76M |
| September 30, 2021 | -86.12M |
| June 30, 2021 | -78.64M |
| March 31, 2021 | -73.41M |
| December 31, 2020 | -67.05M |
| September 30, 2020 | -64.88M |
| June 30, 2020 | -61.67M |
| March 31, 2020 | -57.84M |
| December 31, 2019 | -44.24M |
| September 30, 2019 | -36.80M |
| June 30, 2019 | -30.71M |
| March 31, 2019 | -26.44M |
| December 31, 2018 | -21.02M |
| September 30, 2018 | -22.40M |
| June 30, 2018 | -20.67M |
| March 31, 2018 | -20.62M |
| December 31, 2017 | -20.56M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.80M |
| June 30, 2017 | -18.93M |
| March 31, 2017 | -20.13M |
| December 31, 2016 | -18.43M |
| September 30, 2016 | -23.08M |
| June 30, 2016 | -21.49M |
| March 31, 2016 | -22.18M |
| December 31, 2015 | -24.29M |
| September 30, 2015 | 9.364M |
| June 30, 2015 | 9.834M |
| March 31, 2015 | 11.01M |
| December 31, 2014 | 9.219M |
| September 30, 2014 | -25.89M |
| June 30, 2014 | -27.13M |
| March 31, 2014 | -29.93M |
| December 31, 2013 | -36.68M |
| September 30, 2013 | -40.36M |
| June 30, 2013 | -49.40M |
| March 31, 2013 | -55.60M |
| December 31, 2012 | -56.01M |
| September 30, 2012 | -67.17M |
| June 30, 2012 | -66.81M |
| March 31, 2012 | -66.84M |
| December 31, 2011 | -63.00M |
| September 30, 2011 | -57.89M |
Free Cash Flow Range, Past 5 Years
-168.57M
Minimum
Dec 2023
-30.71M
Maximum
Jun 2019
-92.54M
Average
-86.12M
Median
Sep 2021
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -325.71M |
| SELLAS Life Sciences Group Inc | -36.91M |
| Johnson & Johnson | 17.78B |
| Immuneering Corp | -49.31M |
| Moderna Inc | -3.825B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.94M |
| Cash from Investing (Quarterly) | 47.57M |
| Cash from Financing (Quarterly) | 33.28M |
| Free Cash Flow Per Share (Quarterly) | -0.0689 |
| Free Cash Flow to Equity (Quarterly) | -71.05M |
| Free Cash Flow Yield | -8.06% |